Author:
Lee Chen-Chang,Hsu Shih-Wei,Huang Chi-Wei,Chang Wen-Neng,Chen Sz-Fan,Wu Ming-Kung,Chang Chiung-Chih,Hwang Lain-Chyr,Chen Po-Chou
Funder
Chang Gung Memorial Hospital, Linkou
National Science Council
Publisher
Springer Science and Business Media LLC
Subject
Neurology (clinical),General Medicine
Reference44 articles.
1. Blennow K, de Leon MJ, Zetterberg H. Alzheimer's disease. Lancet. 2006;368(9533):387–403.
2. Chang YT, Chang CC, Lin HS, Huang CW, Chang WN, Lui CC, Lee CC, Lin YT, Chen CH, Chen NC. Montreal cognitive assessment in assessing clinical severity and white matter hyperintensity in Alzheimer's disease with normal control comparison. Acta Neurol Taiwan. 2012;21(2):64–73.
3. Huang CW, Chang WN, Lui CC, Chen CF, Lu CH, Wang YL, Chen C, Juang YY, Lin YT, Tu MC, et al. Impacts of hyper-homocysteinemia and white matter hyper-intensity in Alzheimer's disease patients with normal creatinine: an MRI-based study with longitudinal follow-up. Curr Alzheimer Res. 2010;7(6):527–33.
4. Tu MC, Huang CW, Chen NC, Chang WN, Lui CC, Chen CF, Chen C, Wang YL, Lin YT, Chang CC. Hyperhomocysteinemia in Alzheimer dementia patients and cognitive decline after 6 months follow-up period. Acta Neurol Taiwan. 2010;19(3):168–77.
5. Deppe M, Duning T, Mohammadi S, Schwindt W, Kugel H, Knecht S, Ringelstein EB. Diffusion-tensor imaging at 3 T: detection of white matter alterations in neurological patients on the basis of normal values. Investig Radiol. 2007;42(6):338–45.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献